This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Digene last week denied allegations made by Third Wave Technologies early last month that the company had “abused its monopoly power to thwart competition” in the HPV diagnostics market, and it asked the court to dismiss the charges.
Third Wave’s allegations were made in a countersuit that is part of the firms’ ongoing dispute over a Digene patent covering an HPV diagnostic test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.